We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

44 hedge funds and large institutions have $23.6M invested in Cumberland Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 10

2% more capital invested

Capital invested by funds: $23.2M → $23.6M (+$420K)

8% less funds holding

Funds holding: 48 → 44 (-4)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
44
Holders Change
-4
Holders Change %
-8.33%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
12
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$590K
2
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
+$95.7K
3
AI
Ariel Investments
Illinois
+$73K
4
Renaissance Technologies
Renaissance Technologies
New York
+$58.2K
5
EGA
Eagle Global Advisors
Texas
+$30.4K

Top Sellers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
-$218K
2
SLG
Stanley-Laman Group
Pennsylvania
-$158K
3
CCM
Coldstream Capital Management
Washington
-$70K
4
PP
PDT Partners
New York
-$68K
5
GCP
GSA Capital Partners
United Kingdom
-$60K
Name Holding Trade Value Shares
Change 		Change in
Stake
EA
26
Emerald Acquisition
Washington
$23K +$23.8K +5,198 New
BA
27
BlackRock Advisors
Delaware
$20K – – –
NFA
28
Nationwide Fund Advisors
Ohio
$17K – – –
OC
29
Oakworth Capital
Alabama
$14K – – –
PNC Financial Services Group
30
PNC Financial Services Group
Pennsylvania
$9K -$4.77K -1,042 -34%
BIM
31
BlackRock Investment Management
Delaware
$9K – – –
Citigroup
32
Citigroup
New York
$5K – – –
MFS
33
MSI Financial Services
Massachusetts
$5K +$4.58K +1,000 New
Walleye Trading
34
Walleye Trading
New York
$4K -$8.65K -1,889 -67%
UBS Group
35
UBS Group
Switzerland
$4K +$541 +118 +15%
Deutsche Bank
36
Deutsche Bank
Germany
$4K +$825 +180 +19%
Manulife (Manufacturers Life Insurance)
37
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4K +$1.02K +222 +33%
MA
38
MUFG Americas
New York
$3K – – –
UMA
39
USA Mutuals Advisors
Texas
$3K – – –
SEI Investments
40
SEI Investments
Pennsylvania
$1K – – –
TDC
41
Thompson Davis & Co
Virginia
$1K – – –
SLG
42
Stanley-Laman Group
Pennsylvania
– -$158K -35,078 Closed
CCM
43
Coldstream Capital Management
Washington
– -$70K -15,670 Closed
PP
44
PDT Partners
New York
– -$68K -15,146 Closed
GCP
45
GSA Capital Partners
United Kingdom
– -$60K -13,326 Closed
WIC
46
Woodmont Investment Counsel
Tennessee
– -$9K -2,000 Closed
OSAM
47
O'Shaughnessy Asset Management
Connecticut
– -$8K -1,713 Closed
TRCT
48
Tower Research Capital (TRC)
New York
– -$7.55K -1,649 -94%
Bank of America
49
Bank of America
North Carolina
– +$224 +49 New
1
2

CPIX Hedge Fund Activity: Q2 2016 in Review

44 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q2 2016, worth a combined $23.6M — up 1.8% from $23.2M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CPIX and 4 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 12 added.

The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $590K. The largest seller was BlackRock Institutional Trust, cutting an estimated $218K.

  • 44 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q2 2016, down from 48 in Q1 2016.
  • Funds reported $23.6M of Cumberland Pharmaceuticals stock for Q2 2016, up 1.8% quarter-over-quarter.
  • 4 funds opened new Cumberland Pharmaceuticals positions in Q2 2016 and 7 closed out, a net change of -3 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q2 2016 was Stonepine Capital Management, an estimated $590K added.
  • The largest Cumberland Pharmaceuticals seller in Q2 2016 was BlackRock Institutional Trust, an estimated $218K sold.

Based on aggregated 13F filings for Q2 2016.